<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:18.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
p.bylinebody, li.bylinebody, div.bylinebody
{mso-style-name:bylinebody;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.publisheddate, li.publisheddate, div.publisheddate
{mso-style-name:publisheddate;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.comments, li.comments, div.comments
{mso-style-name:comments;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle26
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>This was passed on by the Chair of PCCN T.O.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><div><div><p class=MsoNormal>Interesting...and easy to implement if proven to be true.<o:p></o:p></p></div><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><div><p class=MsoNormal style='margin-bottom:12.0pt'><br><b>Subject:</b> <b>FYI From <a href="http://telegraph.co.uk">telegraph.co.uk</a> Topic: Prostate cancer test is more reliable if done twice</b><o:p></o:p></p></div></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><div><div><h1><span style='font-size:13.5pt'>Prostate cancer test is more reliable if done twice</span> <o:p></o:p></h1><h2>A team of researchers in Ottawa, Canada, have discovered that unnecessary biopsies can be reduced by 60 per cent <o:p></o:p></h2><div><div><p class=bylinebody>By Nick Hodgson<o:p></o:p></p></div><p class=publisheddate>8:17PM GMT 10 Dec 2015<o:p></o:p></p><p class=comments> <o:p></o:p></p></div><p>A test for <a href="http://www.telegraph.co.uk/news/science/science-news/11621351/Prostate-cancer-breakthrough-as-scientists-crack-genetic-code-behind-nine-in-10-tumours.html" target="_blank">prostate cancer</a> is more reliable if done twice, researchers have found, which could lead to a dramatic fall in unnecessary diagnostic surgery. <o:p></o:p></p><p><o:p> </o:p></p><div><p>The prostate-specific antigen (PSA) test has been used to <a href="http://www.telegraph.co.uk/news/science/science-news/11858609/Prostate-cancer-test-which-detects-tumour-size-could-save-thousands-of-lives.html" target="_blank">help screen for prostate cancer</a> for more than 20 years but it has been found to be unreliable, leading to calls for it to be abandoned. <o:p></o:p></p><p><o:p> </o:p></p></div><div><p>Now a team of researchers in Ottawa, Canada, have discovered that if it is repeated then its reliability increases, <a href="http://www.telegraph.co.uk/news/health/news/11571730/Prostate-cancer-could-be-wiped-out-by-new-treatment.html" target="_blank">reducing unnecessary biopsies by 60 per cent</a>.<o:p></o:p></p></div><div><p><o:p> </o:p></p></div><div><p>The research team reviewed the medical records of 1,268 men who had an abnormal (high) PSA test result and were evaluated at the Ottawa Regional Cancer Assessment Centre between 2008 and 2013. <o:p></o:p></p><p><o:p> </o:p></p></div><p>In 25 percent of these men, the second PSA test came back normal. Only 28 percent of men with conflicting test results underwent a biopsy compared to 62 percent of men who had two <a href="http://www.telegraph.co.uk/news/science/science-news/11858609/Prostate-cancer-test-which-detects-tumour-size-could-save-thousands-of-lives.html" target="_blank">abnormal test results</a>, representing a 60 percent reduction in biopsies. <o:p></o:p></p><p><o:p> </o:p></p><p>In addition, <a href="http://www.telegraph.co.uk/news/science/science-news/11621351/Prostate-cancer-breakthrough-as-scientists-crack-genetic-code-behind-nine-in-10-tumours.html" target="_blank">only three percent of men with conflicting test results</a> who had a biopsy were diagnosed with cancer within the year, compared to 19 percent of men who had two abnormal tests, suggesting that the second normal test is important. <o:p></o:p></p><p><o:p> </o:p></p><p>The study is by The Ottawa Hospital and the University of Ottawa. <o:p></o:p></p><p><o:p> </o:p></p><p>Dr Rodney Breau, one of the lead reserachers, said: “A high PSA level is associated with a greater risk of prostate cancer, and PSA screening can help detect cancer at an earlier, more treatable stage. <o:p></o:p></p><p>"However, PSA levels can also fluctuate because of infections, physical activity and laboratory error. Because of this variation, we implemented a protocol to always repeat an abnormal test before referring a patient for a biopsy. We had a hunch that this would reduce unnecessary biopsies and our study shows that our suspicion was correct." <o:p></o:p></p><p><o:p> </o:p></p><p><o:p> </o:p></p><p><o:p> </o:p></p><p>url:<a href="http://www.telegraph.co.uk/news/health/news/12044908/Prostate-cancer-test-is-more-reliable-if-done-twice.html">http://www.telegraph.co.uk/news/health/news/12044908/Prostate-cancer-test-is-more-reliable-if-done-twice.html</a><o:p></o:p></p></div><p class=MsoNormal>-- <br>You received this message because you are subscribed to the Google Groups "FYI Prostate Info" group.<br>To unsubscribe from this group and stop receiving emails from it, send an email to <a href="mailto:fyi-prostate-info+unsubscribe@googlegroups.com">fyi-prostate-info+unsubscribe@googlegroups.com</a>.<br>To post to this group, send email to <a href="mailto:fyi-prostate-info@googlegroups.com">fyi-prostate-info@googlegroups.com</a>.<br>To view this discussion on the web visit <a href="https://groups.google.com/d/msgid/fyi-prostate-info/726b101d-a57c-4bfc-a10d-c649922eeed4%40googlegroups.com?utm_medium=email&utm_source=footer">https://groups.google.com/d/msgid/fyi-prostate-info/726b101d-a57c-4bfc-a10d-c649922eeed4%40googlegroups.com</a>.<br>For more options, visit <a href="https://groups.google.com/d/optout">https://groups.google.com/d/optout</a>.<o:p></o:p></p></div></blockquote></div></div></body></html>